Does aspirin administration increase perioperative morbidity in patients with cardiac stents undergoing spinal surgery?

Spine

Volumn 40, Issue 9, 2015, Pages 629-635

  Cuellar, Jason M ^a   Petrizzo, Anthony ^a   Vaswani, Ravi ^b   Goldstein, Jeffrey A ^a   Bendo, John A ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antiplatelet; aspirin; aspirin safety; bleeding complication; cardiac stent; perioperative anticoagulation; spinal epidural hematoma; spine surgery

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN; ANTITHROMBOCYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CARDIAC STENT; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DAY HOSPITAL; DEEP VEIN THROMBOSIS; DYSPHAGIA; EPIDURAL HEMATOMA; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; INSTITUTIONAL REVIEW; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LIQUORRHEA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SPINAL HEMATOMA; SPINE SURGERY; STENT; SURGICAL INFECTION; ENDOVASCULAR SURGERY; HEART SURGERY; MIDDLE AGED; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATIONS; SPINE; STATISTICS AND NUMERICAL DATA; SURGERY; THROMBOSIS;

AGED; ASPIRIN; CARDIAC SURGICAL PROCEDURES; COHORT STUDIES; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; ORTHOPEDIC PROCEDURES; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; SPINE; STENTS; THROMBOSIS;

EID: 84958675958     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000695     Document Type: Article

References (27)

1. Ferrari E, Benhamou M, Cerboni P, Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-9
2. Collet JP, Montalescot G, Blanchet B, Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7
3. Iakovou I, Schmidt T, Bonizzoni E, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30
4. Gerstein NS, Schulman PM, Gerstein WH, Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg 2012; 255: 811-9
5. Harty JA, McKenna P, Moloney D, Anti-platelet agents and surgical delay in elderly patients with hip fractures. J Orthop Surg 2007; 15: 270-2
6. Mantz J, Samama CM, Tubach F, Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth 2011; 107: 899-910
7. Chechik O, Thein R, Fichman G, The effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury 2011; 42: 1277-82
8. Kou J, Fischgrund J, Biddinger A, Risk factors for spinal epidural hematoma after spinal surgery. Spine (Phila Pa 1976) 2002; 27: 1670-3
9. Korinth MC, Gilsbach JM, Weinzierl MR,. Low-dose aspirin before spinal surgery: results of a survey among neurosurgeons in Germany. Eur Spine J 2007; 16: 365-72
10. Glotzbecker MP, Bono CM, Wood KB, Postoperative spinal epidural hematoma: a systematic review. Spine (Phila Pa 1976) 2010; 35: E413-20
11. Faul F, Erdfelder E, Lang AG, G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91
12. Kang SB, Cho KJ, Moon KH, Does low-dose aspirin increase blood loss after spinal fusion surgery? Spine J 2011; 11: 303-7
13. Park JH, Ahn Y, Choi BS, Antithrombotic effects of aspirin on 1-or 2-level lumbar spinal fusion surgery: a comparison between 2 groups discontinuing aspirin use before and after 7 days prior to surgery. Spine (Phila Pa 1976). 2013; 38: 1561-5
14. Carragee EJ, Golish SR, Scuderi GJ, A case of late epidural hematoma in a patient on clopidogrel therapy postoperatively: when is it safe to resume antiplatelet agents? Spine J 2011; 11: e1-4
15. Kuchulakanti PK, Chu WW, Torguson R, Correlates and long-Term outcomes of angiographically proven stent thrombosis with sirolimus-And paclitaxel-eluting stents. Circulation 2006; 113: 1108-13
16. Kubo S, Kadota K, Ichinohe T, Comparison of long-Term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis. Circ J 2013; 78: 101-9
17. Schwartz RS, Chronos NA, Virmani R,. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004; 44: 1373-85
18. Kimura T, Morimoto T, Nakagawa Y, Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation 2012; 125: 584-91
19. Natsuaki M, Morimoto T, Furukawa Y, Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-Term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Circ Cardiovasc Interv 2014; 7: 168-79
20. Doyle B, Rihal CS, O'Sullivan CJ, Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007; 116: 2391-8
21. Kocher MS, Zurakowski D,. Clinical epidemiology and biostatistics: a primer for orthopaedic surgeons. J Bone Joint Surg Am 2004; 86-A: 607-20
22. Mehta SR, Tanguay JF, Eikelboom JW, Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010; 376: 1233-43
23. Montalescot G, Drobinski G, Maclouf J, Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris. Circulation 1991; 84: 2054-62
24. Montalescot G, Maclouf J, Drobinski G, Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin. J Am Coll Cardiol 1994; 24: 33-8
25. Roderick PJ, Wilkes HC, Meade TW,. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993; 35: 219-26
26. Yu J, Mehran R, Dangas GD, Safety and efficacy of high-versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv 2012; 5: 1231-8
27. Jolly SS, Pogue J, Haladyn K, Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. Eur Heart J 2009; 30: 900-7